Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Other Non-Current Assets: 2009-2025

Historic Other Non-Current Assets for Lifecore Biomedical (LFCR) over the last 17 years, with May 2025 value amounting to $6.6 million.

  • Lifecore Biomedical's Other Non-Current Assets rose 15.79% to $6.6 million in Q2 2025 from the same period last year, while for May 2025 it was $6.6 million, marking a year-over-year increase of 15.79%. This contributed to the annual value of $6.6 million for FY2025, which is 15.79% up from last year.
  • Latest data reveals that Lifecore Biomedical reported Other Non-Current Assets of $6.6 million as of FY2025, which was up 15.79% from $5.7 million recorded in FY2024.
  • Lifecore Biomedical's Other Non-Current Assets' 5-year high stood at $169.4 million during FY2021, with a 5-year trough of $2.9 million in FY2023.
  • Its 3-year average for Other Non-Current Assets is $5.1 million, with a median of $5.7 million in 2024.
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first spiked by 7,755.61% in 2021, then crashed by 92.58% in 2023.
  • Lifecore Biomedical's Other Non-Current Assets (Yearly) stood at $169.4 million in 2021, then plummeted by 76.79% to $39.3 million in 2022, then crashed by 92.58% to $2.9 million in 2023, then soared by 94.75% to $5.7 million in 2024, then climbed by 15.79% to $6.6 million in 2025.